dr. mayer on toxicities associated with therapies for er breast cancer
Published 8 years ago • 243 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:47
dr. ingrid mayer on targeted therapies in er breast cancer
-
1:57
dr. mayer on tivozanib in renal cell carcinoma and breast cancer
-
1:41
dr. hurvitz on toxicity associated with neratinib in her2 breast cancer
-
0:58
dr. soliman on investigational combination therapies in patients with breast cancer
-
5:42
overcoming endocrine resistance in breast cancer
-
0:55
dr. durand discusses treatment options for toxicities from therapy in her2 breast cancer
-
0:57
dr. moran on techniques to decrease toxicities with radiation in breast cancer
-
4:13
how biomarker testing is improving breast cancer treatment options
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
0:27
toxicities associated with ribociclib from monaleesa-3 trial
-
5:32
first-line er-positive metastatic breast cancer treatments
-
6:57
practical advice on treating her2 metastatic breast cancer
-
0:51
monitor toxicities when treating breast cancer with immunotherapy
-
7:04
treatment for early-stage er breast cancer
-
1:25
dr. ellis on neoadjuvant endocrine therapy for breast cancer
-
1:16
dr. chagpar on surgical treatment of patients with her2 breast cancer
-
1:47
treatment for metastatic breast cancer
-
2:07
emerging toxicities associated with adcs
-
2:32
dr. goetz on treatment challenges for esr1-mutant breast cancer